JPMorgan Chase & Co. Issues Pessimistic Forecast for H.B. Fuller (NYSE:FUL) Stock Price

H.B. Fuller (NYSE:FUL) had its target price decreased by JPMorgan Chase & Co. from $70.00 to $60.00 in a research report sent to investors on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an underweight rating on the specialty chemicals company’s stock.

A number of other research firms also recently weighed in on FUL. Citigroup cut their price target on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research note on Friday, January 3rd. Vertical Research cut H.B. Fuller from a “buy” rating to a “hold” rating in a report on Monday, January 6th. One analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $84.20.

H.B. Fuller Price Performance

FUL stock opened at $62.14 on Friday. The stock has a market capitalization of $3.39 billion, a price-to-earnings ratio of 19.18, a price-to-earnings-growth ratio of 1.50 and a beta of 1.43. The company has a quick ratio of 1.16, a current ratio of 1.89 and a debt-to-equity ratio of 1.10. H.B. Fuller has a 52-week low of $60.96 and a 52-week high of $87.67. The stock’s fifty day simple moving average is $70.82 and its 200-day simple moving average is $76.79.

H.B. Fuller (NYSE:FUL) last issued its quarterly earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). The business had revenue of $923.00 million during the quarter, compared to analyst estimates of $916.84 million. H.B. Fuller had a return on equity of 13.39% and a net margin of 5.15%. The firm’s quarterly revenue was up 2.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.32 earnings per share. Equities research analysts expect that H.B. Fuller will post 3.84 EPS for the current year.

Hedge Funds Weigh In On H.B. Fuller

Several hedge funds and other institutional investors have recently made changes to their positions in FUL. Marshall Wace LLP increased its holdings in H.B. Fuller by 9.9% in the 2nd quarter. Marshall Wace LLP now owns 290,005 shares of the specialty chemicals company’s stock valued at $22,319,000 after purchasing an additional 26,239 shares in the last quarter. S&CO Inc. increased its stake in H.B. Fuller by 0.3% during the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after buying an additional 920 shares during the period. Geode Capital Management LLC lifted its holdings in H.B. Fuller by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after buying an additional 18,734 shares in the last quarter. Lord Abbett & CO. LLC boosted its position in H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after buying an additional 324,056 shares during the last quarter. Finally, Wesbanco Bank Inc. increased its position in shares of H.B. Fuller by 41.2% during the fourth quarter. Wesbanco Bank Inc. now owns 13,700 shares of the specialty chemicals company’s stock worth $924,000 after acquiring an additional 4,000 shares during the last quarter. Institutional investors and hedge funds own 95.93% of the company’s stock.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.